Amgen Asks High Court To Hear Landmark Case
Seeking a high profile review of the 12-year old Markman rule, biotech company Amgen Inc. asked the U.S. Supreme Court on Thursday to decide whether a federal appeals court should give...To view the full article, register now.
Already a subscriber? Click here to view full article